Stocktoria
Lexeo Therapeutics, Inc. LXEO
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-11-03
Lexeo Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 3,845,699 | $22.1M |
| BlackRock Finance, Inc. | 791,584 | $12.7M |
| Point72 Asset Management, L.P. | 1,680,449 | $9.6M |
| MILLENNIUM MANAGEMENT LLC | 1,612,780 | $9.3M |
| AQR CAPITAL MANAGEMENT LLC | 339,623 | $1.9M |
| TWO SIGMA INVESTMENTS, LP | 181,676 | $1.0M |
| D. E. Shaw & Co., Inc. | 30,477 | $174,938 |
Source: SEC EDGAR filings · CIK 0001907108 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.